NanoViricides

A lot of news has been circulating in regards to stocks that could benefit from the recent Ebola virus outbreak.
Although investors might want to proceed with caution when it comes to these news-driven biotech stocks, it never hurts to review the landscape for potential opportunities.
Related...

With the death toll from West Africa’s Ebola outbreak reaching close to 1,000, serious interest is being taken into researching compounds that could both prevent outbreak and help those infected.
Until recently, Ebola was a pretty rare disease, Dr. Jim Wilson told Benzinga, and the...